Mirae Asset Global Etfs Holdings Ltd. Olema Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $56.2 Billion
- Q3 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 27,334 shares of OLMA stock, worth $237,532. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,334Holding current value
$237,532% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding OLMA
# of Institutions
136Shares Held
66.3MCall Options Held
379KPut Options Held
13K-
Bain Capital Life Sciences Investors, LLC Boston, MA6.84MShares$59.5 Million21.2% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY6.79MShares$59 Million2.11% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$46 Million2.76% of portfolio
-
Black Rock Inc. New York, NY4MShares$34.8 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X03.59MShares$31.2 Million0.02% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $351M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...